It's one thing to get a drug approved for use it's quite another for the National Health Service to agree to adopt it. ... ...
Relenza (zanamivir), Glaxo Wellcome's much maligned antiflu drug, has received another knock in the medical press. This time, studies show that the product is too difficult for elderly people to u ...
If at first you don't succeed. . . Governments around the world are taking a dim view of flu vaccines, partly because they're expensive, but also because there is not enough evidence to show they ...
The US and the nations in the European Union have recently pledged donations of US$1.9 billion to “prevent the development of human pandemic influenza”. However, researchers have found that the drugs in the front-line fight against avian flu, should...